# Phosphorylation disrupts the interaction between the intrinsically disordered region of the oncogenic NDRG1 and lipid vesicles

**Authors:** Noemi Carosella, Chiara Pastorello, Jehan Waeytens, Ylenia Beniamino, Valentina Roncassaglia, Lucrezia Serra, Vincent Raussens, Elisabetta Mileo, Stefano Ciurli, Barbara Zambelli

PMC · DOI: 10.1002/pro.70510 · Protein Science : A Publication of the Protein Society · 2026-02-22

## TL;DR

This study explores how phosphorylation affects the NDRG1 protein's interaction with lipid vesicles, potentially offering new insights for treating nickel-related lung cancer.

## Contribution

The study provides a mechanistic understanding of how phosphorylation modulates NDRG1's function as a molecular switch in cancer-related processes.

## Key findings

- Phosphorylation modulates NDRG1's subcellular localization and lipid trafficking.
- NDRG1 toggles between membrane-bound and soluble states via phosphorylation.
- The findings suggest potential therapeutic targets for nickel-driven lung cancer.

## Abstract

NDRG1 is a multifunctional regulatory human protein implicated in crucial cellular processes and acting as a central hub of a cancer‐related interactome. In lung cancer, increased NDRG1 expression is associated with resistance to chemotherapy and is linked to the cellular response to nickel, a known tumor driver in air pollution. Although NDRG1 has been extensively studied in relation to cancer and lipid vesicle recycling, its precise molecular mechanisms remain poorly defined. To address this gap, the present work shifts the focus from previous cellular‐level investigations into a molecular‐level study of NDRG1, dissecting the effects of phosphorylation, metal binding, and lipid interactions. Specifically, we investigated the C‐terminal intrinsically disordered region of the protein that is a key regulatory hub and an attractive target for drug development. Employing a multimodal approach, which combines circular dichroism (CD), nuclear magnetic resonance (NMR), electron paramagnetic resonance (EPR), Fourier‐transform infrared spectroscopy (FT‐IR), and isothermal titration calorimetry (ITC), we developed a mechanistic rationale for how phosphorylation modulates protein subcellular localization, lipid trafficking and storage, acting as a molecular switch that toggles NDRG1 between membrane‐bound, adhesion‐supporting states and soluble, signaling‐competent conformations with metal‐binding activity. These insights open potential opportunities for therapeutic intervention in nickel and pollution‐driven lung cancer.

## Linked entities

- **Genes:** NDRG1 (N-myc downstream regulated 1) [NCBI Gene 10397]
- **Chemicals:** nickel (PubChem CID 935)
- **Diseases:** lung cancer (MONDO:0005138)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, KALRN (kalirin RhoGEF kinase) [NCBI Gene 8997] {aka ARHGEF24, CHDS5, DUET, DUO, HAPIP, KALNC2}, PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292] {aka PIM}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, NDRG3 (NDRG family member 3) [NCBI Gene 57446], SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) [NCBI Gene 10971] {aka 14-3-3, 1C5, HS1}, NDRG2 (NDRG family member 2) [NCBI Gene 57447] {aka SYLD}, NDRG1 (N-myc downstream regulated 1) [NCBI Gene 10397] {aka CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL}, CAT (catalase) [NCBI Gene 847], HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, SPIN1 (spindlin 1) [NCBI Gene 10927] {aka SPIN, TDRD24}
- **Diseases:** colorectal, ovarian, and prostate malignancies (MESH:D010049), hepatocellular carcinoma (MESH:D006528), prostate, pancreatic, colon, hepatocellular and breast carcinoma (MESH:D011472), hypoxia (MESH:D000860), NSCLC (MESH:D002289), renal cell carcinoma (MESH:D002292), cervical, hepatocellular, renal, gastric, and lung cancers (MESH:D013274), hypoxic (MESH:D002534), breast cancer (MESH:D001943), tumorigenesis (MESH:D063646), oncogenes (MESH:D000074723), Cancer (MESH:D009369), lung and nasal cancers (MESH:D008175), metastatic (MESH:D000092182), head and neck cancer (MESH:D006258), prostate cancer (MESH:D011471), metastasis (MESH:D009362)
- **Chemicals:** SDS (MESH:D012967), H (MESH:D006859), Thr (MESH:D013912), 13C (MESH:C000615229), 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol (MESH:C002773), glucose (MESH:D005947), chloramphenicol (MESH:D002701), cholesterol (MESH:D002784), kanamycin (MESH:D007612), IPTG (MESH:D007544), nitroxide (MESH:C039900), amide (MESH:D000577), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (MESH:D004134), D2O (MESH:D017666), phospholipids (MESH:D010743), water (MESH:D014867), chloroform (MESH:D002725), Cys (MESH:D003545), Lipid (MESH:D008055), PI3P (MESH:C055525), glycosphingolipids (MESH:D006028), His (MESH:D006639), N (MESH:D009584), Nickel (MESH:D009532), PI4P (MESH:C037178), phosphatidylserine (MESH:D010718), streptomycin (MESH:D013307), Ala (MESH:D000409), NiSO4 (MESH:C029938), Ser (MESH:D012694), S (MESH:D013455), methanol (MESH:D000432), NaCl (MESH:D012965), metal (MESH:D008670), deuterium (MESH:D003903), 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (-), cis-platin (MESH:D002945), glycerol (MESH:D005990), HEPES (MESH:D006531), TCEP (MESH:C080938), phosphoinositides (MESH:D010716), phosphate (MESH:D010710)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S326, S357, Cys394 was mutated to an Ala, Ser378Cys, Ser/Thr, Cys 394, S330A, Ser357Cys, C394, S336
- **Cell lines:** E. coli BL21(DE3)-RIL — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_B7TK)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928042/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928042/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928042/full.md

---
Source: https://tomesphere.com/paper/PMC12928042